KLRA
Kailera Therapeutics, Inc. · $16.94 (-0.6%) · mkt cap $2.2B

1 hub catalysts across 1 sources · backtest → · ← Ticker Explorer

IPO Lockups (SEC EDGAR)

Signal summary

Converges bullish

Multiple signals point up, none against.

Bullish factors
  • Insiders net buying (5 vs 0)
Bearish factors
  • — none —

Best strategy

2-yr backtest · by Sharpe

Bollinger Bands has fit KLRA best over 2 years (+31.7%, Sharpe 5.59). Historical/in-sample — walk-forward all 19 →

#StrategyReturnSharpeBeats B&H
1Bollinger Bands+31.7%5.59
2Stochastic Oscillator+51.4%2.82
3Williams %R+51.4%2.82

Price — 1 year

daily close
$26.00$16.74$16.94 (-34.8% 1Y)

Insider activity

5 open-market buys

Officers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.

DateActionInsiderSharesValue
2026-04-20BUYKoppel Adam M1,562,500$40.6M
2026-04-20BUYBain Capital Life Sciences Investors, Llc1,562,500$38.5M
2026-04-20BUYRtw Investments, L.P.500,000$12.3M
2026-04-20BUYKaplan Andrew T8,398,438$218.4M
2026-04-20BUYBain Capital Investors, L.L.C.8,398,438$218.4M

Analyst ratings

live · 4 changes
DateActionAnalystRating Change
2026-05-12InitiatedLeerink PartnersOutperform
2026-05-12InitiatedJefferiesBuy
2026-05-12InitiatedEvercore ISI GroupOutperform
2026-05-12InitiatedJP MorganOverweight

Catalyst timeline

1 hub signals
DateSourceEventEntityValue
2026-10-14IPO Lockups (SEC EDGAR)IPO LockupKailera Therapeutics, Inc. IPO lockup expires 2026-10-14180source ↗
Alt-Data Signal Hub · collected signals updated 2026-07-28 18:01 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice

All pages

Catalyst EdgeCongressNewsEarningsSEC FilingsHedge FundsLockupsPositioningMarket cycleBacktestOptionsSourcesGlossaryAbout & API